• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C4 裂解激活补体系统的结构基础。

Structural basis for activation of the complement system by component C4 cleavage.

机构信息

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

出版信息

Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15425-30. doi: 10.1073/pnas.1208031109. Epub 2012 Sep 4.

DOI:10.1073/pnas.1208031109
PMID:22949645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3458355/
Abstract

An essential aspect of innate immunity is recognition of molecular patterns on the surface of pathogens or altered self through the lectin and classical pathways, two of the three well-established activation pathways of the complement system. This recognition causes activation of the MASP-2 or the C1s serine proteases followed by cleavage of the protein C4. Here we present the crystal structures of the 203-kDa human C4 and the 245-kDa C4·MASP-2 substrate·enzyme complex. When C4 binds to MASP-2, substantial conformational changes in C4 are induced, and its scissile bond region becomes ordered and inserted into the protease catalytic site in a manner canonical to serine proteases. In MASP-2, an exosite located within the CCP domains recognizes the C4 C345C domain 60 Å from the scissile bond. Mutations in C4 and MASP-2 residues at the C345C-CCP interface inhibit the intermolecular interaction and C4 cleavage. The possible assembly of the huge in vivo enzyme-substrate complex consisting of glycan-bound mannan-binding lectin, MASP-2, and C4 is discussed. Our own and prior functional data suggest that C1s in the classical pathway of complement activated by, e.g., antigen-antibody complexes, also recognizes the C4 C345C domain through a CCP exosite. Our results provide a unified structural framework for understanding the early and essential step of C4 cleavage in the elimination of pathogens and altered self through two major pathways of complement activation.

摘要

天然免疫的一个重要方面是通过凝集素和经典途径识别病原体表面或自身改变的分子模式,这是补体系统三种已确立的激活途径中的两种。这种识别导致 MASP-2 或 C1s 丝氨酸蛋白酶的激活,随后切割蛋白 C4。在这里,我们展示了 203 kDa 人 C4 和 245 kDa C4·MASP-2 底物·酶复合物的晶体结构。当 C4 与 MASP-2 结合时,C4 会发生大量构象变化,其裂解键区域变得有序,并以丝氨酸蛋白酶的典型方式插入蛋白酶催化位点。在 MASP-2 中,位于 CCP 结构域内的一个外位点从裂解键 60 Å 处识别 C4 的 C345C 结构域。C4 和 MASP-2 残基在 C345C-CCP 界面的突变抑制了分子间相互作用和 C4 的切割。讨论了由糖结合甘露聚糖结合凝集素、MASP-2 和 C4 组成的巨大体内酶-底物复合物的可能组装。我们自己和之前的功能数据表明,通过抗原-抗体复合物等激活的补体经典途径中的 C1s 也通过 CCP 外位点识别 C4 的 C345C 结构域。我们的结果为理解通过补体激活的两种主要途径消除病原体和自身改变的 C4 切割的早期和基本步骤提供了一个统一的结构框架。

相似文献

1
Structural basis for activation of the complement system by component C4 cleavage.C4 裂解激活补体系统的结构基础。
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15425-30. doi: 10.1073/pnas.1208031109. Epub 2012 Sep 4.
2
Investigation of the mechanism of interaction between Mannose-binding lectin-associated serine protease-2 and complement C4.甘露糖结合凝集素相关丝氨酸蛋白酶-2与补体C4相互作用机制的研究
Mol Immunol. 2015 Oct;67(2 Pt B):287-93. doi: 10.1016/j.molimm.2015.06.011. Epub 2015 Jun 27.
3
Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4.甘露聚糖结合凝集素相关丝氨酸蛋白酶 2(MASP-2)的多个结构域对于与底物 C4 的相互作用是必需的。
Mol Immunol. 2012 Jan;49(4):593-600. doi: 10.1016/j.molimm.2011.10.006. Epub 2011 Nov 8.
4
A true autoactivating enzyme. Structural insight into mannose-binding lectin-associated serine protease-2 activations.一种真正的自激活酶。对甘露糖结合凝集素相关丝氨酸蛋白酶-2激活的结构洞察。
J Biol Chem. 2005 Sep 30;280(39):33435-44. doi: 10.1074/jbc.M506051200. Epub 2005 Jul 21.
5
Insight into the intermolecular recognition mechanism involved in complement component 4 activation through serine protease-trypsin.通过丝氨酸蛋白酶-胰蛋白酶深入了解补体成分 4 激活涉及的分子间识别机制。
J Biomol Struct Dyn. 2018 Feb;36(3):575-589. doi: 10.1080/07391102.2017.1288658. Epub 2017 Feb 13.
6
Molecular Interactions Required for Activation of Complement Component C2 Include Exosites Located on the Serine Protease Domain of C1s and Mannose-Binding Lectin Associated Protease-2.分子相互作用需要补体成分 C2 的激活包括位于丝氨酸蛋白酶结构域的 C1s 和甘露糖结合凝集素相关丝氨酸蛋白酶-2 的外显子。
J Immunol. 2024 Apr 1;212(7):1172-1177. doi: 10.4049/jimmunol.2300042.
7
Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules.补体蛋白酶C1s/甘露糖结合凝集素相关丝氨酸蛋白酶-2(MASP-2)嵌合体的功能特性揭示了MASP-2补体控制蛋白模块对C4的更高识别效力。
J Biol Chem. 2005 Dec 23;280(51):41811-8. doi: 10.1074/jbc.M503813200. Epub 2005 Oct 14.
8
Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.阐明凝集素补体途径中MASP-2蛋白酶的底物特异性,并鉴定该酶为丝氨酸蛋白酶抑制剂C1抑制剂的主要生理靶点。
Mol Immunol. 2008 Feb;45(3):670-7. doi: 10.1016/j.molimm.2007.07.008. Epub 2007 Aug 20.
9
TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2.组织因子途径抑制物(TFPI)通过与甘露聚糖结合凝集素相关丝氨酸蛋白酶-2(MASP-2)直接相互作用来抑制补体激活的凝集素途径。
Eur J Immunol. 2015 Feb;45(2):544-50. doi: 10.1002/eji.201445070. Epub 2014 Nov 27.
10
Toward a structure-based comprehension of the lectin pathway of complement.基于结构的补体凝集素途径的理解。
Mol Immunol. 2013 Dec 15;56(3):222-31. doi: 10.1016/j.molimm.2013.05.220. Epub 2013 Jun 27.

引用本文的文献

1
Structural Insights Into Complement Inhibition: Visualizing Distinct Binding Modes of C4b-Binding Protein Complexes With C4b and SAP.补体抑制的结构见解:可视化C4b结合蛋白复合物与C4b和SAP的不同结合模式
Mol Cell Proteomics. 2025 Aug 5;24(9):101046. doi: 10.1016/j.mcpro.2025.101046.
2
Alterations in Gene Expression and Alternative Splicing Induced by Plasmid-Mediated Overexpression of GFP and Within the A549 Cell Line.质粒介导的绿色荧光蛋白(GFP)在A549细胞系中过表达所诱导的基因表达和可变剪接变化
Int J Mol Sci. 2025 Mar 25;26(7):2973. doi: 10.3390/ijms26072973.
3
Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts.纳米粒子结合免疫球蛋白可预测健康和患病队列中补体反应的可变性。
ACS Nano. 2024 Oct 22;18(42):28649-28658. doi: 10.1021/acsnano.4c05087. Epub 2024 Oct 12.
4
The schizophrenia risk gene C4 induces pathological synaptic loss by impairing AMPAR trafficking.精神分裂症风险基因C4通过损害AMPA受体转运诱导病理性突触丧失。
Mol Psychiatry. 2025 Feb;30(2):796-809. doi: 10.1038/s41380-024-02701-7. Epub 2024 Sep 3.
5
SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway.SARS-CoV-2 核衣壳蛋白并非补体凝集素途径过度激活的原因。
Int J Mol Sci. 2024 Jul 4;25(13):7343. doi: 10.3390/ijms25137343.
6
The Crystal Structure of the Michaelis-Menten Complex of C1 Esterase Inhibitor and C1s Reveals Novel Insights into Complement Regulation.C1 酯酶抑制剂与 C1s 的米氏复合体的晶体结构揭示了补体调控的新见解。
J Immunol. 2024 Sep 1;213(5):718-729. doi: 10.4049/jimmunol.2400194.
7
The Lectin Pathway of the Complement System-Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems.补体系统凝集素途径的激活、调控、疾病关联及与其他(蛋白水解)系统的相互作用。
Int J Mol Sci. 2024 Jan 26;25(3):1566. doi: 10.3390/ijms25031566.
8
Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders.Narsoplimab 的研发与特性:一种选择性 MASP-2 抑制剂,用于治疗甘露聚糖结合凝集素途径介导的疾病。
Front Immunol. 2023 Nov 8;14:1297352. doi: 10.3389/fimmu.2023.1297352. eCollection 2023.
9
High-throughput complement component 4 genomic sequence analysis with C4Investigator.高通量补体成分 4 基因组序列分析与 C4Investigator。
HLA. 2024 Jan;103(1):e15273. doi: 10.1111/tan.15273. Epub 2023 Oct 29.
10
Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains.补体通过升高的 IgG3 六聚体平台被激活,并将 C4b 沉积到不同的抗体结构域上。
Nat Commun. 2023 Jul 7;14(1):4027. doi: 10.1038/s41467-023-39788-5.

本文引用的文献

1
Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s.鉴定 C1s 丝氨酸蛋白酶结构域上补体成分 C4 的催化外位。
J Immunol. 2012 Sep 1;189(5):2365-73. doi: 10.4049/jimmunol.1201085. Epub 2012 Aug 1.
2
Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 Are essential for lectin pathway activation and reveal structural plasticity of MASP-2.单特异性抑制剂表明甘露聚糖结合凝集素相关丝氨酸蛋白酶-1(MASP-1)和 -2 对于凝集素途径的激活都是必不可少的,并且揭示了 MASP-2 的结构可塑性。
J Biol Chem. 2012 Jun 8;287(24):20290-300. doi: 10.1074/jbc.M112.354332. Epub 2012 Apr 16.
3
Towards automated crystallographic structure refinement with phenix.refine.利用phenix.refine实现自动化晶体学结构精修
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67. doi: 10.1107/S0907444912001308. Epub 2012 Mar 16.
4
Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4.甘露聚糖结合凝集素相关丝氨酸蛋白酶 2(MASP-2)的多个结构域对于与底物 C4 的相互作用是必需的。
Mol Immunol. 2012 Jan;49(4):593-600. doi: 10.1016/j.molimm.2011.10.006. Epub 2011 Nov 8.
5
Disease-causing mutations in genes of the complement system.补体系统基因中的致病突变。
Am J Hum Genet. 2011 Jun 10;88(6):689-705. doi: 10.1016/j.ajhg.2011.05.011.
6
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury.靶向甘露聚糖结合凝集素相关丝氨酸蛋白酶-2 可预防心肌和胃肠道缺血/再灌注损伤。
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7523-8. doi: 10.1073/pnas.1101748108. Epub 2011 Apr 18.
7
Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.C5-眼镜蛇毒因子复合物中补体转化酶的底物识别
EMBO J. 2011 Feb 2;30(3):606-16. doi: 10.1038/emboj.2010.341. Epub 2011 Jan 7.
8
Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity.收集素 11(CL-11,CL-K1)是一种与 MASP-1/3 相关的血浆收集素,具有微生物结合活性。
J Immunol. 2010 Nov 15;185(10):6096-104. doi: 10.4049/jimmunol.1002185. Epub 2010 Oct 18.
9
Complement: a key system for immune surveillance and homeostasis.补体:免疫监视和稳态的关键系统。
Nat Immunol. 2010 Sep;11(9):785-97. doi: 10.1038/ni.1923. Epub 2010 Aug 19.
10
New insights into the molecular mechanisms of classical complement activation.经典补体激活分子机制的新见解。
Mol Immunol. 2010 Aug;47(13):2154-60. doi: 10.1016/j.molimm.2010.05.011. Epub 2010 Jun 9.